Royalty Pharma is trading 4.11% higher in pre-market at $60.00, with the reason unconfirmed. - The comparison is with the October 1 close of $57.63; the alert is dated October 2, 2026. - Search results showed no new company-specific announcement. The latest surfaced company news was earlier, and recent analyst-target coverage was not dated October 2. - Broader market indicators are modestly higher, while healthcare is reported lower; neither clearly explains the sharp opposite-direction move. The quoted price and percentage are based on the supplied price context.